Endopath-F
- Manufacturer
- Energetix Corp | OHM PHARMA INC.
- Effective date
- 2017-01-02
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 02:08:29
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredients (per drop)
Agnus castus 4X; Angelica sinensis, radix 8X; Cimicifuga racemosa 4X; Fucus vesiculosus 4X; Glandula suprarenalis suis 9X, 12X, 6C; Glycyrrhiza glabra 4X; Hypothalamus 12X, 6C; Oophorinum 9X, 12X, 6C; Pituitarum posterium 12X; Pulsatilla 12X; Sepia 12X; Thyroidinum 9X, 12X, 6C; Xanthoxylum fraxineum 4X.
Purpose
Temporary relief of irregular menses, cramps, mood changes, hot flashes.
INDICATIONS & USAGE SECTION
Uses
Temporary relief of irregular menses, cramps, mood changes, hot flashes.
WARNINGS SECTION
Warnings
- In case of overdose, get medical help or contact a Poison Control Center right away.
- If pregnant or breast feeding, ask a health professional before use.
- Keep out of reach of children.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children
DOSAGE & ADMINISTRATION SECTION
Directions
- Take 30 drops orally twice daily or as directed by a healthcare professional.
- Consult a physician for use in children under 12 years of age or if symptoms worsen or persist.
OTHER SAFETY INFORMATION
Other information
- Store at room temperature out of direct sunlight.
- Do not use if neck wrap is broken or missing.
INACTIVE INGREDIENT SECTION
Inactive ingredients
Ethyl Alcohol, Glycerin, Purified Water.
OTC - QUESTIONS SECTION
OTC - PURPOSE SECTION
Irregular menses, cramps, mood changes, hot flashes.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
energetix
Endopath-F
Homeopathic Remedy
Irregular menses, cramps, mood changes, hot flashes.
2 fl oz (59.1 mL) / 15% Ethyl Alcohol
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 64578-0115-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4483-f424-e053-dadaa90a57ce | Endopath-F |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64578-0115-1 | Endopath-F | 59.1 mL in 1 BOTTLE, DROPPER | LIQUID | 59.1 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 64578-0115 | ENDOPATH-F (HOMEOPATHIC LIQUID) LIQUID [ENERGETIX CORP] | 3 | Legacy NDC, 1 package rows | 20170103_ec2045ae-0ad4-4226-a7b0-1478ece2d6c1.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ANGELICA SINENSIS ROOT | ACTIVE INGREDIENT | B66F4574UG | 2 | |
| BLACK COHOSH | ACTIVE INGREDIENT | K73E24S6X9 | 2 | |
| BOS TAURUS HYPOTHALAMUS | ACTIVE INGREDIENT | S6G2NLH4Y7 | 2 | |
| CHASTE TREE | ACTIVE INGREDIENT | 433OSF3U8A | 2 | |
| FUCUS VESICULOSUS | ACTIVE INGREDIENT | 535G2ABX9M | 2 | |
| GLYCYRRHIZA GLABRA | ACTIVE INGREDIENT | 2788Z9758H | 2 | |
| PULSATILLA VULGARIS | ACTIVE INGREDIENT | I76KB35JEV | 2 | |
| SEPIA OFFICINALIS JUICE | ACTIVE INGREDIENT | QDL83WN8C2 | 2 | |
| SUS SCROFA ADRENAL GLAND | ACTIVE INGREDIENT | 398IYQ16YV | 2 | |
| SUS SCROFA OVARY | ACTIVE INGREDIENT | S7YTV04R8O | 2 | |
| SUS SCROFA PITUITARY GLAND | ACTIVE INGREDIENT | E8S87O660T | 2 | |
| THYROID, UNSPECIFIED | ACTIVE INGREDIENT | 0B4FDL9I6P | 2 | |
| ZANTHOXYLUM AMERICANUM BARK | ACTIVE INGREDIENT | A4KL1HMZ7T | 2 | |
| ANGELICA SINENSIS ROOT | ACTIVE MOIETY | B66F4574UG | 2 | |
| BLACK COHOSH | ACTIVE MOIETY | K73E24S6X9 | 2 | |
| BOS TAURUS HYPOTHALAMUS | ACTIVE MOIETY | S6G2NLH4Y7 | 2 | |
| CHASTE TREE | ACTIVE MOIETY | 433OSF3U8A | 2 | |
| FUCUS VESICULOSUS | ACTIVE MOIETY | 535G2ABX9M | 2 | |
| GLYCYRRHIZA GLABRA | ACTIVE MOIETY | 2788Z9758H | 2 | |
| PULSATILLA VULGARIS | ACTIVE MOIETY | I76KB35JEV | 2 | |
| SEPIA OFFICINALIS JUICE | ACTIVE MOIETY | QDL83WN8C2 | 2 | |
| SUS SCROFA ADRENAL GLAND | ACTIVE MOIETY | 398IYQ16YV | 2 | |
| SUS SCROFA OVARY | ACTIVE MOIETY | S7YTV04R8O | 2 | |
| SUS SCROFA PITUITARY GLAND | ACTIVE MOIETY | E8S87O660T | 2 | |
| THYROID, UNSPECIFIED | ACTIVE MOIETY | 0B4FDL9I6P | 2 | |
| ZANTHOXYLUM AMERICANUM BARK | ACTIVE MOIETY | A4KL1HMZ7T | 2 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 2 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Products#
Every source-derived product name is available through these pages.
- Endopath-F
- Homeopathic Liquid
- CHASTE TREE
- BLACK COHOSH
- FUCUS VESICULOSUS
- GLYCYRRHIZA GLABRA
- BOS TAURUS HYPOTHALAMUS
- ANGELICA SINENSIS ROOT
- SUS SCROFA OVARY
- PULSATILLA VULGARIS
- SEPIA OFFICINALIS JUICE
- THYROID, UNSPECIFIED
- ZANTHOXYLUM AMERICANUM BARK
- SUS SCROFA PITUITARY GLAND
- SUS SCROFA ADRENAL GLAND
- WATER
- GLYCERIN
- ALCOHOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 64578-0115 | 64578-0115-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CHASTE TREE | 433OSF3U8A | ACTIB |
| BLACK COHOSH | K73E24S6X9 | ACTIB |
| FUCUS VESICULOSUS | 535G2ABX9M | ACTIB |
| GLYCYRRHIZA GLABRA | 2788Z9758H | ACTIB |
| BOS TAURUS HYPOTHALAMUS | S6G2NLH4Y7 | ACTIB |
| ANGELICA SINENSIS ROOT | B66F4574UG | ACTIB |
| SUS SCROFA OVARY | S7YTV04R8O | ACTIB |
| PULSATILLA VULGARIS | I76KB35JEV | ACTIB |
| SEPIA OFFICINALIS JUICE | QDL83WN8C2 | ACTIB |
| THYROID, UNSPECIFIED | 0B4FDL9I6P | ACTIB |
| ZANTHOXYLUM AMERICANUM BARK | A4KL1HMZ7T | ACTIB |
| SUS SCROFA PITUITARY GLAND | E8S87O660T | ACTIB |
| SUS SCROFA ADRENAL GLAND | 398IYQ16YV | ACTIB |
| WATER | 059QF0KO0R | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| ALCOHOL | 3K9958V90M | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d36f87be-fda9-4125-9337-130fb7a04b64 | ec2045ae-0ad4-4226-a7b0-1478ece2d6c1 | 2017-01-02 | Warnings | d36f87be-fda9-4125-9337-130fb7a04b64 ec2045ae-0ad4-4226-a7b0-1478ece2d6c1 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
